In a rat double-hit model of burn injury followed two days later by cecal ligation and puncture (CLP)-induced sepsis, the anti-inflammatory cytokine IL-10 rises significantly in the late phase (day 4) only in the less severe variant (burn plus sham-CLP) while the more severe burn-plus-CLP group shows no significant long-term IL-10 change, and the computationally inferred transcription factors (including the ETS-family factor ETS1 and CCAAT-enhancer-binding protein, CEBP) proposed to regulate the altered cytokines and chemokines were identified only from conserved promoter regions without experimental validation. The open problem is to determine experimentally how the late IL-10-dominated negative feedback is initiated and maintained in systemic inflammation after burn plus sham-CLP (sterile) injury, why it is context-dependent, and whether the inferred transcription factor-to-cytokine regulatory links and the observed IL-10/TNF-alpha temporal anticorrelation are causal in the injury setting.

Background

Interleukin-10 (IL-10) is the principal anti-inflammatory cytokine of the innate immune response: produced by monocytes, macrophages, dendritic cells, neutrophils, B cells and T cells, it activates the transcription factor STAT3 (signal transducer and activator of transcription 3), which induces SOCS3 (suppressor of cytokine signaling 3), a negative-feedback inhibitor of inflammatory cytokines such as TNF-alpha, IL-6 and IL-1. Sepsis and major burn trauma trigger systemic inflammation whose later phase is shaped by counter-regulatory, anti-inflammatory signaling, yet the mechanisms that switch this brake on, and off, remain only partly understood. Orman, Ierapetritou, Berthiaume and Androulakis (Cytokine 2012, doi:10.1016/j.cyto.2012.01.017) profiled 23 serum cytokines and chemokines over 10 days in four rat groups: controls, burn plus sham-CLP (B+SCLP, sterile injury), sham-burn plus CLP (S+CLP, infection alone), and the double-hit burn plus CLP (B+CLP), where CLP (cecal ligation and puncture) is the standard polymicrobial sepsis model and a 20% total-body-surface-area full-thickness burn models severe sterile trauma. Chemokines such as MCP-1 (monocyte chemoattractant protein-1, also called CCL2) and GRO/KC (the rat homolog of human IL-8) recruit leukocytes to injured tissue. Using one-way ANOVA of the time courses, they found that IL-10 increased significantly only on day 4 in the less severe B+SCLP group, with no significant long-term IL-10 change in the more severe B+CLP group; in B+SCLP, TNF-alpha rose on day 3 and declined on day 4 exactly when IL-10 rose, a correlative signature of negative feedback. To suggest regulatory mechanisms, the authors computationally inferred putative transcription factors (TFs) - proteins that bind gene promoters to control transcription - by analyzing evolutionarily conserved promoter regions (the Genomatix promoter-sequence analysis database) of the significantly altered mediators. This analysis flagged the ETS family (E-twenty-six specific transcription factors, notably ETS1) as putative regulators of about ten mediators including MCP-1 and GRO/KC, and CEBP (CCAAT-enhancer-binding protein) as putative regulator of IL-6, IL-10 and TNF-alpha. The paper itself presents these links as putative rather than experimentally established: well-studied factors such as NFKB (nuclear factor kappa B, a master controller of pro-inflammatory gene transcription), STAT and CEBP have documented roles in burn and sepsis, but for ETS1, SP1 (specificity protein 1), GATA (GATA-binding factors) and VTBP (a TATA-binding-protein-family factor) the authors state only that they might play important roles during inflammation by regulating cytokine production. No chromatin immunoprecipitation, reporter, or gene-perturbation experiments were performed. Adjacent literature shows the inference is biologically plausible - Ets-1 transactivates MCP-1 in vascular smooth muscle in cerebral aneurysm (Aoki et al., Gene Therapy 2010, doi:10.1038/gt.2010.60), CCL2 activates Ets-1 in brain endothelium (Stamatovic et al., J Immunol 2006, doi:10.4049/jimmunol.177.4.2651), Ets-1 represses IL-10 in Th1 (T helper 1) cells (Lee et al., J Immunol 2012, doi:10.4049/jimmunol.1101614), and Ets-1 induces IL-10 transcription after HIV-1 Tat stimulation (Li and Lau, Immunology 2007, doi:10.1111/j.1365-2567.2007.02580.x) - but these results come from unrelated tissues and disease contexts, and the direction of Ets-1 action on IL-10 differs between them, so they settle nothing for burn and sepsis. Later summary work confirms the gap persists: a 2024 systematic review of 352 animal burn studies found long-lasting proinflammatory surges but noted that the response of anti-inflammatory mediators was limited in the available data (Mulder et al., J Invest Dermatol 2024, doi:10.1016/j.jid.2023.09.269), and a 2026 review of IL-10 in sepsis describes the multilayer regulation of IL-10 - transcriptional programs, cytokine circuits, immunometabolism - and its context-dependent, time-shifting balance between protection and immunoparalysis as an active research frontier (Wang et al., Inflammation 2026, doi:10.1007/s10753-026-02512-8).

Problem Statement

Determine, by experimental mechanistic evidence in the double-hit burn and sepsis setting, how the late-phase IL-10-centered anti-inflammatory negative feedback is initiated and maintained in systemic inflammation, and whether the regulatory architecture computationally inferred in Orman et al. (Cytokine 2012, doi:10.1016/j.cyto.2012.01.017) is causal. Concretely: (1) identify the cellular sources and the upstream inductive signals and transcriptional regulators that drive late-phase IL-10 production after burn plus sham-CLP (sterile) injury, and explain why significant late IL-10 induction occurs in the less severe burn+sham-CLP context but not in the more severe burn+CLP context; (2) experimentally establish or refute the transcription factor-to-target links inferred from conserved-promoter analysis in Orman et al., the required links being exactly ETS1 as putative regulator of MCP-1 and GRO/KC and CEBP as putative regulator of IL-6, IL-10 and TNF-alpha, in the injury context, for example by transcription-factor perturbation with measurement of the target mediator dynamics; and (3) test whether the observed temporal anticorrelation between IL-10 and pro-inflammatory cytokines (TNF-alpha declining as IL-10 rises) reflects causal IL-10-mediated negative feedback rather than parallel resolution of the pro-inflammatory response. A resolution must address each of (1)-(3) and consists of a mechanistic account together with a concrete experimental design and testable predicted outcomes.

References

  1. Orman MA, Ierapetritou MG, Berthiaume F, Androulakis IP. Long-term dynamic profiling of inflammatory mediators in double-hit burn and sepsis animal models. Cytokine 2012;58(2):307-315. DOI: 10.1016/j.cyto.2012.01.017, PMID 22402033. https://doi.org/10.1016/j.cyto.2012.01.017
  2. Orman MA, Nguyen TT, Ierapetritou MG, Berthiaume F, Androulakis IP. Comparison of the cytokine and chemokine dynamics of the early inflammatory response in models of burn injury and infection. Cytokine 2011;55(3):362-371. DOI: 10.1016/j.cyto.2011.05.010, PMID 21652218. https://doi.org/10.1016/j.cyto.2011.05.010
  3. Rao R, Orman MA, Berthiaume F, Androulakis IP. Dynamics of hepatic gene expression and serum cytokine profiles in single and double-hit burn and sepsis animal models. Data in Brief 2015;3:229-233. DOI: 10.1016/j.dib.2015.02.018, PMID 26217749. https://doi.org/10.1016/j.dib.2015.02.018
  4. Mulder PPG, Hooijmans CR, Vlig M, Middelkoop E, Joosten I, Koenen HJPM, Boekema BKHL. Kinetics of Inflammatory Mediators in the Immune Response to Burn Injury: Systematic Review and Meta-Analysis of Animal Studies. Journal of Investigative Dermatology 2024;144(3):669-696. DOI: 10.1016/j.jid.2023.09.269, PMID 37806443. https://doi.org/10.1016/j.jid.2023.09.269
  5. Wang X, Huang Q, Dai J, Zhang L, Qian Z. The Dual Role of Interleukin-10 in Sepsis: Research Progress and Therapeutic Prospects. Inflammation 2026;49(1). DOI: 10.1007/s10753-026-02512-8, PMID 42020831. https://doi.org/10.1007/s10753-026-02512-8
  6. Aoki T, Kataoka H, Nishimura M, Ishibashi R, Morishita R, Miyamoto S. Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells. Gene Therapy 2010;17(9):1117-1123. DOI: 10.1038/gt.2010.60, PMID 20428211. https://doi.org/10.1038/gt.2010.60
  7. Stamatovic SM, Keep RF, Mostarica-Stojkovic M, Andjelkovic AV. CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. Journal of Immunology 2006;177(4):2651-2661. DOI: 10.4049/jimmunol.177.4.2651, PMID 16888027. https://doi.org/10.4049/jimmunol.177.4.2651
  8. Lee CG, Kwon HK, Sahoo A, Hwang W, So JS, Hwang JS, Chae CS, Kim GC, Kim JE, So HS, Hwang ES, Grenningloh R, Ho IC, Im SH. Interaction of Ets-1 with HDAC1 represses IL-10 expression in Th1 cells. Journal of Immunology 2012;188(5):2244-2253. DOI: 10.4049/jimmunol.1101614, PMID 22266280. https://doi.org/10.4049/jimmunol.1101614
  9. Li JC, Lau AS. A role for mitogen-activated protein kinase and Ets-1 in the induction of interleukin-10 transcription by human immunodeficiency virus-1 Tat. Immunology 2007;121(3):337-348. DOI: 10.1111/j.1365-2567.2007.02580.x, PMID 17376198. https://doi.org/10.1111/j.1365-2567.2007.02580.x
  10. Qian LW, Evani SJ, Chen P, Brandenburg KS, Weaver AJ, Fourcaudot AB, Abercrombie JJ, Sebastian EA, Leung KP. Cerium Nitrate Treatment Provides Eschar Stabilization through Reduction in Bioburden, DAMPs, and Inflammatory Cytokines in a Rat Scald Burn Model. Journal of Burn Care and Research 2020;41(3):576-584. DOI: 10.1093/jbcr/irz199, PMID 31808807. https://doi.org/10.1093/jbcr/irz199